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Abstract 
We reviewed an initial experience using a miniaturized transesophageal 
echocardiography (TEE) probe (ImaCor, Garden City, NY) with 3 patients in whom 
Imacor hTEE intervention was used as a point of care device to manage extracorporeal 
membrane oxygenation cannula placement, cardiac hemodynamics, and post-op cardiac 
pathophysiology. The management of transplant or mechanical circulatory support 
(MCS) patients is especially challenging: transplanted hearts pose unique 
pathophysiological challenges, and MCS significantly alters pressure-volume-flow 
relationships.  Real-time “hemodynamic” TEE (hTEE) can help provide effective 
management by direct visualization of cardiac filling and function and help guide 
hemodynamic management.  In our initial experience, hTEE can provide point-of-care 
management following transplant or MCS.  (Word count of abstract: 105) 
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Introduction 
Fluid and hemodynamic management, fundamental in critical care, becomes 
significantly more challenging in transplant patients and patients with mechanical 
circulatory support.  Transplanted hearts pose unique pathophysiological challenges1, 2, 
and mechanical support significantly alters pressure-volume-flow relationships.  These 
alterations can further limit the utility of standard pressure measurements, both central 
venous pressure and pulmonary artery pressure.  Central venous pressure has been shown 
to have a poor relationship with volume status.3   The Swan-Ganz catheter provides 
indirect measurements that can be difficult to interpret; moreover altered pressure-
volume-flow relationships.  Transesophageal echocardiography (TEE) directly visualizes 
the heart, allowing accurate assessment of cardiac function and volume status with other 
parameters. 4  Cardiac anesthesiologists rely on TEE images to make hemodynamic 
assessments and interventions in the cardiac operating room.  TEE would appear to be the 
ideal tool for hemodynamic assessment and management of critically ill patients5, 
provided that availability and the need for trained personnel and anesthesia can be 
overcome.  An editorial called for a TEE probe which could remain indwelling 48 hours 
in critically ill patients.6 
To address these issues, a miniaturized TEE probe (hTEE probe, ImaCor, Garden 
City, NY) with a diameter of 5.5 mm was developed to provide hemodynamic 
management and assessment in critical care to aid in assessment of volume status and 
cardiac function with other parameters.  The hTEE probe was cleared by the FDA to 
remain indwelling up to 72 hours.  The hTEE probe has 15 cm of penetration at 6.67 
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MHz (B-mode) and can obtain the images of left and right ventricular function and 
volume status.7 
Methods 
We reviewed our initial experience with 3 patients in whom the Imacor hTEE system was 
used as a point-of-care device to manage extracorporeal membrane oxygenation (ECMO) 
cannula placement, cardiac hemodynamics, and post-op cardiac pathophysiology.  This 
study was approved by an institutional review board at Thomas Jefferson University 
Hospital. 
Results 
Case 1: A 55-year-old female with a history of dilated cardiomyopathy, presented for a 
heart transplantation evaluation.  She quickly decompensated into multiple organ failure 
despite significant inotropic support.  It was decided that emergent Veno-arterial ECMO 
placement for biventricular support was necessary (Figure 1A).  Over 3 weeks of VA 
ECMO support, the patient was deemed not a candidate for heart transplantation.  
Although the patient remained eligible for a left ventricular (LV) assist device, right 
ventricular (RV) function had not been evaluated prior to decompensation. 
A weaning protocol was initiated with hTEE for direct visualization of cardiac 
function to assess RV function.  Over four hours, ECMO flows were decreased, and 
volume and dobutamine were administered.  hTEE showed that the right heart was 
adequate to tolerate a bridge to LVAD (Figure 1B).  The patient was successfully weaned 
off ECMO and bridged to an LVAD as predicted. 
Case 2: A 47-year-old male with a Heartmate II LVAD (Thoratec, Pleasanton, CA) 
underwent orthotropic heart transplantation.  Postoperatively, the patient required 
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escalating vasopressors despite good cardiac function determined by a Swan-Ganz 
catheter using both thermodilution and mixed venous saturation.  Twelve hours later, the 
Swan-Ganz catheter showed tamponade physiology with equalization of pulmonary 
artery diastolic pressure (26 mm Hg) and central venous pressure (25 mm Hg) with 
decreased cardiac index (2.0 L/min/cm2).  An hTEE probe was placed to assess to 
evaluate LV and RV cardiac function; no tamponade was seen (Figure 2A). Real time 
imaging with continuous hTEE demonstrated deteriorating biventricular function to near 
cardiac standstill (Figure 2B). Based on hTEE visualization, central ECMO was 
established as a rescue support. 
Case 3: A 58-year-old female with an acute anterior ST-elevation myocardial infarction 
underwent a percutaneous catheter intervention to the left anterior descending artery.  
During this intervention, she developed a complete AV block and cardiogenic shock.  
Her hemodynamics did not improve despite multiple inotropes and an intra-aortic balloon 
pump placement.  An Impella (Abiomed, Danvers, MA) was emergently placed for 
circulatory support.  However, it was complicated with a retroperitoneal hematoma and 
dislodgement of the Impella device.  The patient developed severe pulmonary edema and 
was transferred to our institution for VA ECMO placement.  As soon as VA ECMO was 
established at a flow of 4 to 4.5 liters/min, her hemodynamics significantly improved and 
stabilized.  Approximately 6 hours later, her ECMO flows suddenly dropped to 2 
liters/min.  There were no changes of CVP (10 mm Hg) or PA pressure (32/12 mm Hg).  
A fluid challenge did not improve the flow. The hTEE probe was inserted and revealed a 
large right atrial thrombus interfering with the inflow to the venous cannula (Figure 3A).  
The ECMO cannula was adjusted bedside and heparin administration was initiated.  The 
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atrial clot was monitored real time using the hTEE probe (Figure 3B) and the clot 
dissolved over 24 hours. 
Discussion 
These 3 cases illustrate how Imacor hTEE intervention was used as a point of care 
device to manage extracorporeal membrane oxygenation (ECMO) cannula placement, 
cardiac hemodynamics, and post-op cardiac pathophysiology. The management of 
transplant or mechanical circulatory support patients is especially challenging: 
transplanted hearts pose unique pathophysiological challenges, and mechanical 
circulatory support significantly alters pressure-volume-flow relationships.  Real-time 
“hemodynamic” TEE (hTEE) can help provide effective management by direct 
visualization of cardiac filling and function and help guide hemodynamic management. 
 Weaning from ECMO requires recovery of either RV and/or LV cardiac 
function. Although the first patient had persistent LV dysfunction, RV function recovered 
after 3 weeks of ECMO support. This allowed the patient to receive a HeartMateII 
LVAD.  ECMO weaning requires ongoing observation of cardiac function through major 
circulatory changes which are visualized by real time continuous hTEE. A ECMO 
weaning protocol includes a gradual decrease of ECMO flows from full (usually 4-5 
liter/min) to minimum flow (1.5-2 litter/min) over 4 to 6 hours, with appropriate 
increased anticoagulation to avoid clot formation, volume to fill the heart, and inotropic 
support such as dobutamine or milrinone to optimize ventricular contractility along with 
careful hemodynamic monitoring for arrhythmias, oxygenation, and blood pressure.8 
Adequate filling pressures or adequate cardiac output do not necessarily imply adequate 
RV or LV function for patient on ECMO.  Placement of a Swan-Ganz catheter (SGC) 
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may be difficult with a venous cannula in a decompressed right atrium. A central mixed 
venous gas analysis would also be useful to evaluate the circulation and function of the 
heart; however, the lag between the sampling the blood and results may makes ongoing 
real-time adjustments difficult.  The hTEE probe provides real time images of the heart, 
allowing the intensivist to determine if the preload is appropriate and cardiac function is 
adequate and intervene rapidly if necessary.  If the heart distends during weaning, one 
can immediately return to the full ECMO support to avoid the further cardiac damage 
over-distension.  If ventricular recovery is questionable, hTEE probe can be left in the 
patient for continuous monitoring of the cardiac function, potentially saving the cost of 
taking the patient to the operating room. 
Primary biventricular failure post-transplantation, as seen in Case 2, may be 
related to poor myocardial preservation of the donor, prolonged ischemic time, residual 
pulmonary hypertension, and decreased compliance of the lungs post cardiopulmonary 
bypass.1,2 The HeartMate II LVAD in Case 2 decompressed the left ventricle, artificially 
lowering pulmonary artery pressure (Pap) and masking residual high pulmonary vascular 
resistance.  Heart transplant patient with prolonged ischemic time and elevated recipient 
pulmonary vascular resistance often develop RV failure, which can progress to 
biventricular failure.2 
RV dysfunction post heart transplant may cause SGC parameters to mimic cardiac 
tamponade. A SGC can also reproduce unreliable readings with diastolic dysfunction due 
to the presence of a hematoma and myocardial edema. Cardiac tamponade should be 
readily diagnosed by TEE (including hTEE); however, due to our limited prior 
experience with hTEE, the patient was explored surgically and no tamponade was found.  
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If we followed our hTEE findings, we would have avoided surgical exploration, a 
significant cost saving.10  This patient’s RV failure progressed to biventricular failure and 
was retrospectively found to be caused by graft rejection. As seen here, indirect 
hemodynamic monitoring may be inadequate to diagnose RV or graft failure post-
transplant.  Moreover, in the presence of escalating vasopressor support secondary to 
systemic vasoplegia syndrome, normal pressure may not yield normal perfusion.  This 
lack of normal perfusion was the apparent cause of near ventricular standstill detected by 
hTEE, a condition which if not managed by central ECMO might otherwise have led to 
cardiac arrest. 
Case 3 illustrates an acute emergency in ECMO patients requiring rapid diagnosis 
and management, namely lack of or sharply reduced flow.  Sharply reduced flow is 
usually related to the volume status of the patient, and resolved by administering volume.  
Sharply reduced flow shortly after ECMO placement may also be due to cannula 
malposition. In case 3 a thrombus in the right atrium occluded the cannula, a rare 
phenomenon. The hTEE probe allows us to visualization the thrombus, and its separation 
from the cannula following manipulation, at which time ECMO flow returned to normal.  
The hTEE probe was left indwelling until stabilization of ECMO flows (48 hours) to 
evaluate the right atrial thrombus.  We were able to avoid unnecessary fluid boluses, 
which could be harmful in the presence of pulmonary edema. 
Conclusion 
We found hTEE helped guide point-of-care management of patients post-
transplant or with mechanical circulatory support accurately and acutely.10 Although 
further study is needed, hTEE appeared easy to use by intensivists on demand and 
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yielded significant management changes, potentially avoiding re-operation with 
concomitant mortality and morbidity11 as well as cost. 
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Figure Legends 
Figure 1.  A. Biventricular failure at the time of ECMO insertion.  B. RV function 
improved with 3 weeks of ECMO support although the LV remained dilated.  LV: left 
ventricle; RV: right ventricle.  Line in the RV indicates RV dimension.  Please note the 
RV dimension is smaller in Figure 1B than 1A, indicating the recovery of RV function. 
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Figure 2. A. hTEE shows no cardiac tamponade.  B. Cardiac standstill initiated 
immediate ECMO support.  LV: left ventricle; RV: right ventricle. 
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Figure 3. A. Transesophageal echocardiography with hTEE probe reveals thrombus 
(indicated by arrow) appearing to block ECMO venous cannula in right atrium (indicated 
by ellipse, cannula visible as parallel lines) – a possible cause for decreased flow (2 
L/min), the presumed diagnosis after hTEE examination.  B. Adjustment of cannula 
(indicated by ellipse, cannula visible as parallel lines) and ECMO RPM displaced and 
released the thrombus (indicated by arrow) from the catheter opening – this was further 
confirmed by resumption of ECMO flow at 4.5 L/min. 
 
